Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
João Ferreira MD, PhD

João Pedro Ferreira MD, PhD

Senior Clinical Investigator, Cardiovascular Research and Development Center (UnIC), Department of Surgery and Physiology, Faculty of Medicine,University of Porto, Porto, Portugal; Université de Lorraine, Nancy, France

Dr. Ferreira is a full Professor at the Faculty of Medicine of the University of Porto, where he is responsible for the clinical trial unit. He is also a collaborator with the University of Lorraine and Nancy Hospital in France. He is interested in heart failure, hypertension, diabetes, obesity, fibrosis and aldosterone.

Disclosures

Dr Ferreira is a consultant for Boehringer-Ingleheim. He has received research funding from Astra Zeneca and Novartis. 

Recent Contributions to PracticeUpdate:

  1. Obesity and Effects of Dapagliflozin on Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes

Most Read This Week

Recently Updated